Our findings revealed that higher expression levels of EGR3, GSN, LEF1, and NEDD9 were correlated with improved prognosis in breast cancer, while elevated expression of AVPR1A, FEZ1, and HGF yielded contrasting results, as depicted in Supplementary Figure S1. Here, NEDD9 is linked to breast cancer.